USA - NASDAQ:AZN - US0463531089 - ADR
ChartMill assigns a Buy % Consensus number of 82% to AZN. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-02-13 | UBS | Upgrade | Neutral -> Buy |
| 2024-11-20 | UBS | Upgrade | Sell -> Neutral |
| 2024-09-11 | Erste Group | Upgrade | Hold -> Buy |
| 2024-08-12 | TD Cowen | Maintains | Buy -> Buy |
| 2024-05-30 | Argus Research | Maintains | Buy -> Buy |
| 2024-05-30 | Goldman Sachs | Initiate | Buy |
| 2024-04-26 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-04-16 | Deutsche Bank | Upgrade | Sell -> Hold |
| 2024-02-12 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-02-08 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2024-01-23 | Morgan Stanley | Initiate | Overweight |
| 2024-01-03 | Jefferies | Downgrade | Buy -> Hold |
| 2023-09-25 | Jefferies | Upgrade | Hold -> Buy |
| 2023-09-08 | Erste Group | Downgrade | Buy -> Hold |
| 2023-08-01 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-05-26 | Argus Research | Maintains | Buy -> Buy |
| 2023-04-13 | Argus Research | Maintains | Buy |
| 2023-01-05 | BMO Capital | Initiate | Outperform |
| 2022-11-14 | SVB Leerink | Maintains | Outperform |
| 2022-11-11 | SVB Leerink | Maintains | Outperform |
| 2022-08-29 | Argus Research | Upgrade | Hold -> Buy |
| 2022-05-04 | SVB Leerink | Maintains | Outperform |
| 2022-02-24 | SVB Leerink | Maintains | Outperform |
| 2022-02-11 | DZ Bank | Upgrade | Sell -> Hold |
| 2021-12-07 | Jefferies | Downgrade | Buy -> Hold |
| 2021-09-27 | SVB Leerink | Maintains | Outperform |
| 2021-09-20 | SVB Leerink | Maintains | Outperform |
| 2021-08-10 | Deutsche | Reiterate | Reiteration |
| 2021-08-10 | Deutsche Bank | Reiterate | Buy |
| 2021-08-09 | Shore Capital | Reiterate | Reiteration |
33 analysts have analysed AZN and the average price target is 90.41 USD. This implies a price increase of 10.17% is expected in the next year compared to the current price of 82.07.
The consensus rating for ASTRAZENECA PLC-SPONS ADR (AZN) is 81.8182 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering ASTRAZENECA PLC-SPONS ADR (AZN) is 33.